The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Astepro Allergy
Azelastine HCl · AZELASTINE HYDROCHLORIDE 205.5 ug/1 · Spray, Metered · Nasal · Bayer HealthCare LLC.
NDC 00280-0065-01 · 60 CARTON in 1 BOTTLE / 1 SPRAY, METERED in 1 CARTON · NDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- NDA213872
- TE code
- —
- Approval date
- Jun 17, 2021
- Patents / exclusivity
- 2 patents, 0 exclusivities
| Type | Number / code | Expires |
|---|---|---|
| patent | 8071073 | Jun 4, 2028 |
| patent | 8071073 | Jun 4, 2028 |
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Azelastine HCl (Spray, Metered)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Bayer HealthCare LLC. | AZELASTINE HYDROCHLORIDE 205.5 ug/1 | Jul 15, 2026 | Aug 31, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Astepro Allergy — NDC 00280-0065-01," retrieved September 3, 2026, https://drugdashboards.com/drug/00280006501.
Free to cite with attribution — see how the data is put together.